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GPB1 and GPB2 encode kelch repeat-containing proteins that regulate protein kinase A (PKA) in yeast by a cAMP-
independent process. Here we show that Gpb1 and Gpb2 stimulate phosphorylation of PKA regulatory subunit Bcy1 in
low glucose concentrations, thereby promoting the inhibitory function of Bcy1 when nutrients are scarce and PKA activity
is expected to be low. Gpb1 and Gpb2 stimulate Bcy1 phosphorylation at an unknown site, and this modiﬁcation
stabilizes Bcy1 that has been phosphorylated by PKA catalytic subunits at serine-145. The BCY1S145A mutation eliminates
the effect of gpb1 gpb2 on Bcy1 stability but maintains their effect on phosphorylation and signaling, indicating that
modulation of PKA activity by Gpb1 and Gpb2 is not solely due to increased levels of Bcy1. Inhibition of PKA catalytic
subunits that are ATP analog-sensitive causes increased Bcy1 phosphorylation at the unknown site in high glucose. When
PKA is inhibited, gpb1 gpb2 mutations have no effect on Bcy1 phosphorylation. Therefore, Gpb1 and Gpb2 oppose
PKA activity by blocking the ability of PKA to inhibit Bcy1 phosphorylation at a site other than serine-145. Stimulation
of Bcy1 phosphorylation by Gpb1 and Gpb2 produces a form of Bcy1 that is more stable and is a more effective PKA
inhibitor.
INTRODUCTION
Protein kinase A (PKA) is a component of eukaryotic signal-
ing pathways that is activated by a conserved mechanism
that involves binding of cAMP to the PKA regulatory sub-
unit and the resulting release of active catalytic kinase sub-
units. In the yeast Saccharomyces cerevisiae, PKA is essential
for viability and is activated by nutrient signals (Dechant
and Peter, 2008; Zaman et al., 2008; Rubio-Texeira et al., 2009;
Smets et al., 2010). High levels of PKA activity in yeast cause
inhibition of stress responses and induction of pseudohy-
phal and invasive growth. Yeast contain three forms of the
PKA catalytic subunit, called Tpk1, Tpk2, and Tpk3, and one
form of the regulatory subunit, called Bcy1 (Toda et al.,
1987a,b). Although the most well-established mechanism of
PKA regulation is its activation by binding of cAMP, studies
using yeast mutants that lack adenylate cyclase have sug-
gested that PKA could be regulated in other ways (Lu and
Hirsch, 2005; Peeters et al., 2006). Uncovering an alterna-
tive mechanism of PKA regulation in yeast could be rel-
evant to the other systems that employ this common
signaling component.
The yeast G protein -subunit Gpa2 and its coupled re-
ceptor Gpr1 activate a signaling pathway that optimizes
normal growth, inhibits stress responses, and promotes
pseudohyphal growth, similar to the effects of high levels of
PKA activation (Ku ¨bler et al., 1997; Lorenz and Heitman,
1997; Colombo et al., 1998; Xue et al., 1998). Gpr1 is present
on the cell surface and appears to function as a low-afﬁnity
glucose receptor that responds to high concentrations of
glucose in the extracellular environment (Xue et al., 1998;
Kraakman et al., 1999; Rolland et al., 2000; Welton and
Hoffman, 2000; Lemaire et al., 2004). GPR1 and GPA2 are not
essential genes, and phenotypes resulting from deletion of
GPR1 and GPA2 can be suppressed by addition of extracel-
lular cAMP (Ku ¨bler et al., 1997; Lorenz and Heitman, 1997;
Lorenz et al., 2000; Tamaki et al., 2000). The idea that Gpa2
stimulates adenylate cyclase to produce cAMP, similar to
mammalian Gs, is supported by evidence showing that
cells lacking Gpa2 are defective for the spike in cAMP levels
that is induced by the addition of glucose (Colombo et al.,
1998; Kraakman et al., 1999; Lorenz et al., 2000). Moreover,
the GTP-bound form of Gpa2 has been shown to bind pref-
erentially to adenylate cyclase (Peeters et al., 2006). These
results demonstrate that one function of Gpa2 is to stimulate
adenylate cyclase to produce cAMP and activate PKA.
The yeast kelch repeat proteins Gpb1 and Gpb2 were
identiﬁed based on their ability to interact with Gpa2 in a
yeast two-hybrid screen (Harashima and Heitman, 2002;
Batlle et al., 2003; Peeters et al., 2006). Analysis of the se-
quence of the GPB1 (also called KRH2) and GPB2 (also called
KRH1) gene products indicates that they contain either six
(Batlle et al., 2003) or seven (Harashima and Heitman, 2002)
kelch repeats, which are predicted to fold into a -propeller
structure (Adams et al., 2000). Because Gpa2 does not appear
to associate with classical G protein -subunits and the kelch
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3749repeat proteins are predicted to fold into the same structure
as -subunits, it was originally proposed that Gpb1 and
Gpb2 function as G protein -subunit mimics for Gpa2
(Harashima and Heitman, 2002). However, genetic analysis
does not support the idea that the kelch repeat proteins
function as -subunit mimics (for review, see Peeters et al.,
2007). Moreover, it has been shown that the domain of Gpa2
that binds to Gpb1 and Gpb2 is not the region of the -sub-
unit that binds to -subunits (Niranjan et al., 2007). Recently,
another WD repeat protein has been proposed to function as
the -subunit for Gpa2 (Zeller et al., 2007). These results
indicate that Gpb1 and Gpb2 are unlikely to function as G
protein -subunit mimics for Gpa2.
Cells that lack Gpb1 and Gpb2 display an increase in
pseudohyphal and invasive growth, indicating that the
kelch repeat proteins are negative regulators of the signaling
pathway (Harashima and Heitman, 2002; Batlle et al., 2003).
A number of observations support the idea that Gpb1 and
Gpb2 negatively regulate signaling by directly inhibiting the
activity of PKA. It was initially shown that the increase in
pseudohyphal and invasive growth conferred by gpb1
gpb2 mutations requires the PKA catalytic subunit Tpk2
(Harashima and Heitman, 2002; Batlle et al., 2003). Subse-
quently, it was shown that deletion of GPB1 and GPB2
stimulates the growth of cells that contain a constant level of
cAMP, suggesting that Gpb1 and Gpb2 affect the activity of
PKA by a process that does not involve changes in cAMP
levels (Lu and Hirsch, 2005; Peeters et al., 2006). Moreover,
deletion of GPB1 and GPB2 causes an increase in phosphor-
ylation of PKA substrates in vivo, indicating that PKA ac-
tivity is affected by the presence of Gpb1 and Gpb2 (Lu and
Hirsch, 2005). The PKA regulatory subunit Bcy1 is also
required for the increase in signaling conferred by gpb1
gpb2 mutations (Peeters et al., 2006). And ﬁnally, Gpb2 has
been shown to interact with Tpk1, Tpk2, and Tpk3 (Peeters
et al., 2006). These results strongly suggest that the inhibitory
function of Gpb1 and Gpb2 acts directly on PKA.
Several different functions for Gpb1 and Gpb2 have been
proposed by others to explain their effects on signal trans-
duction. The proposed mechanisms include a role for Gpb1
and Gpb2 in inhibition of receptor-G protein coupling
(Harashima and Heitman, 2005), positive regulation of Ras
GTPase activating proteins (Harashima et al., 2006), and
stimulation of the association between PKA regulatory and
catalytic subunits (Peeters et al., 2006). The results presented
here support the idea that Gpb1 and Gpb2 promote the
association between PKA regulatory and catalytic subunits
by stimulating Bcy1 phosphorylation and stabilization in
opposition to the activity of PKA catalytic subunits. In cells
that lack Gpb1 and Gpb2, Bcy1 becomes unstable, which
results in a higher proportion of free active catalytic subunits
and an increase in PKA activity.
MATERIALS AND METHODS
Strains and Media
Strains used in this study are listed in Table 1. Construction of strains
containing the gpb1::URA3 and gpb2::HIS3 alleles (Batlle et al., 2003), the
gpa2::TRP1 allele (Xue et al., 1998), and the gpb2::TRP1, tpk1-1::TRP1,
tpk2-2::TRP1, and tpk3-3::HIS3 alleles (Lu and Hirsch, 2005) were described
previously. The gpb1::TRP1 allele was made by transformation of a
gpb1::URA3 strain with a 3.8-kb SmaI fragment from marker swap plasmid
pUT11 (Cross, 1997). The ras2::HIS3 allele was made by transformation of cells
with the 6.1-kb EcoRI fragment from plasmid pras2::HIS3, which contains the
HIS3 gene inserted into the PstI site of the RAS2 gene. The yak1::LEU2 allele
was made by transformation of cells with the 4.3-kb HindIII-SmaI fragment
from plasmid pGS136-B (Garrett and Broach, 1989). The bcy1::URA3 allele was
made by transformation of cells with the 5.3-kb BamHI fragment from plas-
mid pbcy1::URA3 (Toda et al., 1987a).
Yeast cells were grown on YEPD (2% glucose), and strains under selection
were grown on synthetic dropout media, as described (Xue et al., 1998).
Plasmid Construction
Plasmid 313pBHB1-416 (Grifﬁoen et al., 2000) was kindly provided by Gerard
Grifﬁoen (reMYND, Brussels, Belgium). Plasmids pBCS145E-313.3, pBCS145D-
313.4, and pBHBSA-313.4 are identical to 313pBHB1-416, except that codon
145 of BCY1 was changed from TCT to GAG, GAT, or GCT, respectively, by
site-directed mutagenesis. Plasmid pRAS2AV-111.9 contains the activated
RAS2ala18val19 allele in vector YCplac111.
Yeast Methods and RNA Isolation
To test the effect of low glucose concentrations, cells were grown to early log
phase, washed once, and resuspended in the medium lacking glucose. Glu-
cose was added to a ﬁnal concentration of 2, 0.2, 0.05, or 0.005%, cells were
incubated for3ha t30°C with shaking, and cells lysates were prepared.
Alternatively, cells were grown to early log phase overnight in 2, 0.2, or 0.05%
glucose.
For Bcy1 half-life determination, cycloheximide (Sigma, St. Louis, MO) was
added to cells growing in log phase to a ﬁnal concentration of 100 g/ml. At
various time points after cycloheximide addition (0–120 min), aliquots were
removed and centrifuged to pellet the cells. 1.5 ml of cold stop buffer (50 mM
Tris-Cl, pH 7.5, 50 mM NaF, and 0.1% NaN3) was added to the cell pellet,
which was centrifuged brieﬂy and snap-frozen in liquid nitrogen. Cell lysates
were prepared from the frozen pellets as described below.
For inhibition of PKA, 1NM-PP1 (VWR Scientiﬁc, West Chester, PA) was
added to cells growing in log phase to a ﬁnal concentration of 1 or 5 M, cells
were incubated for 90 min with shaking, and cell lysates were prepared as
described below.
Table 1. Strains used in this study
Strain Genotype Source














HS275-1Ca MATa gpa2::TRP1 This study
HS275-9Ba MATa gpa2::TRP1 ras2::HIS3 This study
HS275-16Ca MATa ras2::HIS3 This study
HS278.T-1Da MATa gpb1::TRP1 gpb2::HIS3
ras2::HIS3
This study
HS281-2Ca MATa gpb1::TRP1 gpb2::HIS3
gpa2::TRP1
This study
HS282-23Ca MATa gpb1::TRP1 gpb2::HIS3
gpa2::TRP1 ras2::HIS3
This study











W3031B MAT leu2-3,112 trp1-1 can1-












a SKY762 background; SKY762 is derived from 1278b.
b W303 background.
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time RT-PCR was performed on a LightCycler version 3.5 instrument (Roche,
Indianapolis, IN), as described previously (Niranjan et al., 2007).
Immunoblots and Immunoprecipitation Assays
Lysates for immunoblots and immunoprecipitation assays were prepared
from cells growing in log phase (OD600  0.3–0.85) as described previously
(Lu and Hirsch, 2005), with the modiﬁcation that cells were lysed in 100–200
l lysis buffer (20 mM K2HPO4, pH 7.4, 0.5% TX-100, 25 mM NaF, 100 M
Na3VO4, 2 mM EDTA, 2 mM EGTA, 1 mM PMSF, 1 protease inhibitor
cocktail [Roche], and 10 phosSTOP phosphatase inhibitor cocktail [Roche]).
An equal amount of total protein from each lysate was loaded and resolved
by 8% SDS-PAGE or 4–15% gradient SDS-PAGE and analyzed by immuno-
blotting. Blots were probed with the following antibodies: anti-hemagglutinin
(HA) 12CA5 mAb at a dilution of 1/1000, anti-myc 9E10 mAb at a dilution of
1/1000, anti-phospho-PKA substrate (RRXS/T) rabbit mAb (Cell Signaling,
Beverly, MA) at a dilution of 1/1000, anti-phosphoglycerate kinase (PGK)
rabbit polyclonal antiserum at a dilution of 1/300,000, and anti-actin rabbit
polyclonal antibody (Sigma) at a dilution of 1/1000. Quantiﬁcation of immu-
noblots was performed using the infrared dye–labeled secondary antibodies
IRDye 800CW goat anti-mouse IgG (Li-Cor, Lincoln, NE) at a dilution of
1/10,000 and IRDye 680 goat anti-rabbit IgG (Li-Cor) at a dilution of 1/10,000.
The infrared signal was scanned using the Odyssey Infrared Imaging System
(Cincinnati, OH).
For immunoprecipitations, samples containing 500 g of total protein were
incubated with 3–4 g of anti-myc 9E10 antibody for at least2ha t4 ° Cwith
constant mixing. The samples were then incubated with 50 l of 50% protein
G-agarose slurry (Roche) for at least three hours or overnight at 4°C. The
samples were washed three times with cold wash buffer (50 mM Tris-Cl, pH
7.4, 150 mM NaCl,1 mM EDTA, 1 protease inhibitor cocktail [Roche], and
10 phosSTOP phosphatase inhibitor cocktail [Roche]), and proteins were
resolved by SDS-PAGE and analyzed by immunoblotting.
RESULTS
Effect of gpb1 gpb2 Mutations on Signaling Requires
PKA Catalytic Subunits
The kelch repeat proteins Gpb1 and Gpb2 control PKA activity
by negatively regulating one or more components of the PKA/
cAMP pathway. Potential targets of negative regulation by
Gpb1 and Gpb2 include Gpa2 (Harashima and Heitman, 2002;
Batlle et al., 2003), Ras GTPase-activating proteins (GAPs;
Harashima et al., 2006), and the cAMP-dependent kinase
PKA (Peeters et al., 2006). To investigate the effect of GPB1
and GPB2 on these signaling components, a real time RT-
PCR assay for FLO11 RNA abundance was performed in
various mutant strains. The FLO11 gene, which encodes a
cell surface ﬂocculin, is induced in response to increases in
cAMP levels in strains that are capable of undergoing
pseudohyphal and invasive growth (Rupp et al., 1999).
Deletion of GPB1 and GPB2 results in a substantial
increase in FLO11 RNA abundance in both wild-type
and gpa2 strains (Figure 1A), as described previously
(Harashima and Heitman, 2002; Batlle et al., 2003). The same
effect is seen in a ras2 strain (Figure 1A). Quantiﬁcation of
the results showed that there is a six- to sevenfold increase
in FLO11 RNA levels in gpb1 gpb2 strains compared with
the corresponding GPB1 GPB2 strains in wild-type and
ras2 backgrounds. Although there is a very little FLO11
RNA present in a gpa2 strain, the level of FLO11 RNA in a
gpa2 gpb1 gpb2 strain is just slightly less than that seen in
a GPA2 gpb1 gpb2 strain, as described previously
(Harashima and Heitman, 2002; Batlle et al., 2003). These
results demonstrate that the effect of gpb1 gpb2 mutations
is not solely dependent on either RAS2 or GPA2. To test
whether Gpa2 and Ras GAPs comprise all the targets of
Gpb1 and Gpb2, FLO11 RNA levels were measured in
strains that lack both Gpa2 and Ras2. In a gpa2 ras2 strain,
FLO11 RNA is present at a very low level (Figure 1A).
However, deletion of GPB1 and GPB2 in such a strain con-
fers a signiﬁcant threefold increase in the amount of FLO11
RNA over the basal level. This result indicates that at least
one target of Gpb1 and Gpb2 regulation is capable of trans-
mitting a signal in a strain that lacks both Gpa2 and Ras2.
To test the possibility that PKA is a major target of Gpb1
and Gpb2, FLO11 RNA levels were measured in strains
containing deletions of the PKA catalytic subunit genes.
Because the triple deletion of TPK1, TPK2, and TPK3 pro-
duces a lethal phenotype, the viability of this strain was
maintained by a yak1 mutation (Garrett and Broach, 1989).
In a tpk1 tpk2 tpk3 yak1 strain, FLO11 RNA is present at
a very low level (Figure 1B). Deletion of GPB1 and GPB2 in
such a strain does not cause an increase in the amount of
FLO11 RNA. In cells containing a yak1 mutation alone,
deletion of GPB1 and GPB2 results in a substantial increase
in FLO11 RNA abundance, demonstrating that the yak1
allele has no effect on the phenotype conferred by the gpb1
Figure 1. Deletion of GPB1 and GPB2 has no effect in cells that lack
PKA catalytic subunits. (A) RNA was isolated from the following
strains and assayed for the relative amount of FLO11 and ACT1
RNA by real-time RT-PCR: wild-type strain SKY762, strain HS182-
3B.k2T (gpb1 gpb2), strain HS275-16C (ras2), strain HS278.T-1D
(gpb1 gpb2 ras2), strain HS275-1C (gpa2), strain HS281-2C
(gpb1 gpb2 gpa2), strain HS275-9B (gpa2 ras2), and strain
HS282-23C (gpb1 gpb2 gpa2 ras2). Values are plotted as the
relative amount of FLO11 RNA normalized to ACT1 RNA and are
the mean and SD from three independent experiments. *p  0.0001.
(B) RNA was isolated from the following strains and assayed for the
relative amount of FLO11 and ACT1 RNA by real-time RT-PCR as
described in A: wild-type strain SKY762, strain HS182-3B.k2T
(gpb1 gpb2), strain HS297-2B (yak1), strain HS300-17B (gpb1
gpb2 yak1), strain HS260-2B (tpk1 tpk2 tpk3 yak1), and strain
HS257-12D (gpb1 gpb2 tpk1 tpk2 tpk3 yak1).
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subunits are required for the effect of Gpb1 and Gpb2 on
signaling.
Previous results have shown that Gpb1 and Gpb2 do not
function by regulating adenylate cyclase, because deletion of
GPB1 and GPB2 has an effect in cells containing a deletion of
the adenylate cyclase gene CYR1 (Lu and Hirsch, 2005;
Peeters et al., 2006). Therefore, a reasonable interpretation of
these ﬁndings is that Gpb1 and Gpb2 act directly on PKA to
inhibit its activity. This idea is consistent with the previous
observation that both the catalytic and regulatory subunits
of PKA are required for the effect of gpb1 gpb2 mutations
on the accumulation of reserve carbohydrates (Peeters et al.,
2006).
Phosphorylation and Abundance of Bcy1 Are Affected by
gpb1 gpb2 Mutations When Glucose Concentrations
Are Low
In yeast, PKA is involved in the response to extracellular glu-
cose through a complex network of nutrient signaling path-
ways (Dechant and Peter, 2008; Zaman et al., 2008; Rubio-
Texeira et al., 2009; Smets et al., 2010). Cells that contain high
PKA activity do not respond appropriately to decreased
glucose concentration. Given that Gpb1 and Gpb2 are neg-
ative regulators of PKA activity, it is possible that the phys-
iological role of these proteins is to inhibit PKA activity
under conditions of low glucose. In cells lacking all PKA
catalytic subunits, gpb1 gpb2 mutations do not affect sig-
naling (Figure 1; Peeters et al., 2006). However, in cells
containing any one of the three PKA subunits, gpb1 gpb2
mutations confer an increase in signaling (Lu and Hirsch,
2005). One way in which Gpb1 and Gpb2 could control the
activity of all PKA catalytic subunits is by affecting the sole
PKA regulatory subunit, Bcy1. As glucose is depleted from
the medium, Bcy1 increases in abundance and becomes
phosphorylated at serine-145, the autocatalytic site, and at
multiple unknown sites (Werner-Washburne et al., 1991;
Grifﬁoen et al., 2001). These changes are thought to contrib-
ute to the decrease in PKA activity under these conditions.
These observations raise the possibility that Gpb1 and Gpb2
inhibit PKA activity by affecting the abundance or modiﬁ-
cation of Bcy1 under conditions of low glucose.
To determine whether Gpb1 and Gpb2 are involved in the
response to low glucose, wild-type and gpb1 gpb2 cells
grown to log phase in 2% glucose were transferred to me-
dium containing lower concentrations of glucose, and pro-
tein levels of HA-Bcy1 were measured by immunoblot. For
the wild-type strain, transferring cells to 0.2, 0.05, or 0.005%
glucose caused a substantial increase in Bcy1 levels (Figure
2A, lanes 1–4). The degree of Bcy1 phosphorylation also
increased in response to lower concentrations of glucose. For
the gpb1 gpb2 strain, transferring cells to low glucose
concentrations resulted in Bcy1 levels that were more than
10-fold lower than the levels present in wild-type cells
grown at the same glucose concentrations (Figure 2A, lanes
5–8). Moreover, the degree of Bcy1 phosphorylation was not
substantially changed in gpb1 gpb2 cells in response to
lower concentrations of glucose. These results strongly sug-
gest that Gpb1 and Gpb2 play a role in reducing PKA
activity in response to low levels of extracellular glucose.
The results shown above indicate that deletion of GPB1
and GPB2 has multiple effects on Bcy1 in response to glucose
concentration. These effects could be due to changes in tran-
scription of the BCY1 gene, changes in stability of the Bcy1
protein, or modiﬁcation of Bcy1. PKA activity is subject to
feedback regulation through regulation of cAMP break-
down (Nikawa et al., 1987; Mbonyi et al., 1990; Ma et al.,
1999), which suggests that some of these effects could be
indirect consequences of high PKA activity in gpb1 gpb2
cells. To investigate which effects of gpb1 gpb2 mutations
on Bcy1 are likely to be indirect, the state of Bcy1 was
examined in gpa2 ras2 cells, which contain a very low
level of PKA activity. Whereas Bcy1 in wild-type cells grown
in high glucose is not detectably phosphorylated, Bcy1 in
gpa2 ras2 cells displays a substantial degree of phosphor-
ylation (Figure 2B). Phosphorylated Bcy1 is present at a
much lower level in gpa2 ras2 cells that also contain gpb1
gpb2 mutations. The abundance of Bcy1 is essentially the
same in gpa2 ras2 cells that contain either GPB1 GPB2 or
gpb1 gpb2 alleles. These results suggest that the primary
effect of gpb1 gpb2 mutations is to alter the degree of Bcy1
phosphorylation.
BCY1S145A Mutation Eliminates the Effect of gpb1 gpb2
Mutations on Bcy1 Stability
Bcy1 is known to be phosphorylated by several kinases,
including the catalytic subunits of PKA itself (Kuret et al.,
1988; Werner-Washburne et al., 1991; Grifﬁoen et al., 2001,
2003). PKA catalytic subunits phosphorylate Bcy1 at a single
site, serine-145 (Kuret et al., 1988; Werner-Washburne et al.,
1991). To investigate whether phosphorylation at this site
plays a role in the regulation of PKA by Gpb1 and Gpb2,
codon 145 of BCY1 was changed from serine to alanine.
Protein levels were measured using immunoblots incubated
with ﬂuorescently labeled secondary antibodies, which were
detected with an infrared imaging system to allow accurate
quantiﬁcation.
In wild-type cells grown in a high concentration of glu-
cose, Bcy1 is present at an approximately three- to fourfold
Figure 2. Deletion of GPB1 and GPB2 affects phosphorylation and
abundance of Bcy1. (A) Cell lysates were prepared from strains
HS287-2C (bcy1) and HS293-10D (gpb1 gpb2 bcy1) carrying
plasmid 313pBHB1-416 that were grown in 2% glucose to log phase
and then switched to the indicated concentrations of glucose for 3 h.
Lysates were analyzed by SDS-PAGE and immunoblotting with
anti-HA and anti-PGK antibodies. (B) Cell lysates were prepared
from wild-type strain SKY762 carrying vector YCplac33 and from
the following strains carrying plasmid 313pBHB1-416: wild-type
strain SKY762, strain HS182-3B.k2T (gpb1 gpb2), strain HS275-9B
(gpa2 ras2), and strain HS282-23C (gpb1 gpb2 gpa2 ras2).
Cells were grown in 2.0% glucose to log phase, and lysates were
analyzed by SDS-PAGE and immunoblotting with anti-HA and
anti-PGK antibodies.
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cells (Figures 3A, lanes 1 and 2). However, the Bcy1S145A
variant is present at the same level in both GPB1 GPB2 and
gpb1 gpb2 cells (Figure 3A, lanes 3 and 4). Thus, changing
the PKA phosphorylation site in Bcy1 to a site that cannot be
phosphorylated eliminates the effect of the gpb1 gpb2
mutations on Bcy1 abundance. The phenotype of cells con-
taining the Bcy1S145A variant is slow growth (Werner-Wash-
burne et al., 1991), which probably results from the failure of
PKA to become fully activated due to excess levels of the
altered regulatory subunit.
To determine the effect of changing the PKA phosphory-
lation site in Bcy1 to amino acids that mimic a phosphory-
lated residue, codon 145 of BCY1 was changed from serine
to either glutamic acid or aspartic acid. The Bcy1S145E and
Bcy1S145D variants are present at a lower level in gpb1
gpb2 cells than in GPB1 GPB2 cells, although the difference
is not as substantial as that seen with wild-type Bcy1 (Figure
3B). Repeat experiments have conﬁrmed that this is due to a
slight decrease in the abundance of Bcy1S145E and Bcy1S145D
in wild-type cells. However, the results clearly show that the
effect of gpb1 gpb2 mutations on Bcy1 abundance is re-
tained by forms of Bcy1 in which serine-145 is replaced by
amino acids that mimic a phosphorylated residue.
The observation that deleting GPB1 and GPB2 causes a
three- to fourfold decrease in the steady-state level of Bcy1
suggests that the function of Gpb1 and Gpb2 could involve
regulating the half-life of the Bcy1 protein. To test this idea,
cells were treated with cycloheximide to arrest protein trans-
lation, and the amount of Bcy1 remaining was examined at
increasing times after blocking its synthesis. In wild-type
cells, the level of Bcy1 remains constant throughout the time
course of the experiment, indicating that it is extremely
stable (Figure 3C, lanes 1–5). In gpb1 gpb2 cells, the level
of Bcy1p decreases during the time course (Figure 3C, lanes
6–10). Multiple trials of this experiment and quantiﬁcation
of the protein levels demonstrated that the half-life of Bcy1p
in gpb1 gpb2 cells is 80–85 min. In contrast, the level of
Bcy1S145A remains constant throughout the time course of
the experiment in both GPB1 GPB2 and gpb1 gpb2 cells
(Figure 3D). The Bcy1S145E variant displays levels that are
constant in wild-type cells, but decrease in gpb1 gpb2 cells
Figure 3. The BCY1S145A mutation eliminates the effect of gpb1 gpb2 mutations on Bcy1 stability. (A) Cell lysates were prepared from the
following strains: strain HS287-2C (bcy1) carrying plasmid 313pBHB1-416 (HA-BCY1, WT), strain HS293-10D (gpb1 gpb2 bcy1) carrying
plasmid 313pBHB1-416, strain HS287-2C carrying plasmid pBHBSA-313.4 (HA-BCY1, SA), strain HS293-10D carrying plasmid pBHBSA-313.4,
and wild-type strain SKY762 carrying vector pRS313. Lysates were analyzed by SDS-PAGE and immunoblotting with anti-HA and anti-PGK
antibodies. Protein levels were quantiﬁed by infrared imaging, and numbers under the lanes are the relative amount of HA-Bcy1 normalized
to PGK. (B) Cell lysates from the following strains were analyzed as described in A: strain HS287-2C (bcy1) carrying plasmid 313pBHB1-416
(HA-BCY1, WT), strain HS293-10D (gpb1 gpb2 bcy1) carrying plasmid 313pBHB1-416, strain HS287-2C carrying plasmid pBCS145E-313.3
(HA-BCY1, SE), strain HS293-10D carrying plasmid pBCS145E-313.3, strain HS287-2C carrying plasmid pBCS145D-313.4 (HA-BCY1, SD), and
strain HS293-10D carrying plasmid pBCS145D-313.4. (C) Strains HS287-2C (bcy1) and HS293-10D (gpb1 gpb2 bcy1) carrying plasmid
313pBHB1-416 were treated with cycloheximide (100 g/ml) at time 0, and lysates were made from samples removed at the indicated times.
Lysates were analyzed by SDS-PAGE and immunoblotting with anti-HA and anti-PGK antibodies. (D) Strains HS287-2C (bcy1) and
HS293-10D (gpb1 gpb2 bcy1) carrying plasmid pBHBSA-313.4 were treated as described in C. (E) Strains HS287-2C (bcy1) and HS293-10D
(gpb1 gpb2 bcy1) carrying plasmid pBCS145E-313.3 were treated as described in C. (F) Protein levels from the blots shown in C–E were
quantiﬁed by infrared imaging, and the relative amount of HA-Bcy1 normalized to PGK was plotted as the percent remaining over time,
using the following symbols: ‚, 313pBHB1-416 in HS287-2C; Œ, 313pBHB1-416 in HS293-10D; , pBHBSA-313.4 in HS287-2C; f, pBHBSA-313.4
in HS293-10D; E, pBCS145E-313.3 in HS287-2C; F, pBCS145E-313.3 in HS293-10D.
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ﬁcation of these results showed that whereas wild-type Bcy1
and Bcy1S145E decay with similar kinetics in gpb1 gpb2
cells, Bcy1S145A levels are unchanged during the time course
in gpb1 gpb2 cells (Figure 3F). These results indicate that
the absence of Gpb1 and Gpb2 causes a decrease in the
half-life of Bcy1. Moreover, the results show that the de-
creased half-life of Bcy1 depends on its ability to be phos-
phorylated on serine-145.
Effects of gpb1 gpb2 Mutations on Bcy1
Phosphorylation and PKA Activity Are Not Eliminated
by BCY1S145A
Gpb1 and Gpb2 affect both phosphorylation and stability of
Bcy1. Because the BCY1S145A mutation eliminates the effect
of gpb1 gpb2 mutations on Bcy1 stability, it was possible
to use this mutation to determine whether the effect of Gpb1
and Gpb2 on phosphorylation is dependent on their effect
on stability. To test this idea, wild-type and gpb1 gpb2
cells containing wild-type HA-BCY1, HA-BCY1S145A, and
HA-BCY1S145E were grown to log phase in 0.05% glucose,
and HA-Bcy1 was detected by immunoblot. For wild-type
BCY1 and the BCY1S145E allele, the abundance and phos-
phorylation level of Bcy1 were decreased in gpb1 gpb2
cells (Figure 4A, lanes 1, 2, 5, and 6). For the BCY1S145A
allele, the abundance Bcy1 was unaffected by gpb1 gpb2
mutations, but the level of phosphorylation was decreased
(Figure 4A, lanes 3 and 4). These ﬁndings indicate that Gpb1
and Gpb2 can have an effect on Bcy1 phosphorylation in the
absence of an effect on its abundance. This conclusion pro-
vides further support for the idea that the primary effect of
gpb1 gpb2 mutations is to alter the degree of Bcy1 phos-
phorylation. The results also show that a form of Bcy1 that
cannot be phosphorylated at the PKA site retains its ability
to be differentially phosphorylated at another site in a man-
ner dependent on Gpb1 and Gpb2.
To test whether the change in Bcy1 abundance caused by
the S145A mutation has an effect on signaling, cells contain-
ing HA-BCY1, HA-BCY1S145A, and HA-BCY1S145E as their
only copy of BCY1 were assayed for FLO11 RNA expression.
In cells containing wild-type BCY1, deletion of GPB1 and
GPB2 causes a sevenfold increase in FLO11 RNA levels, as
expected (Figure 4B). The level of FLO11 RNA is dramati-
cally reduced in gpb1 gpb2 cells containing BCY1S145A
compared with the same cells containing wild-type BCY1.
This decrease in signaling output is probably due to the
increase in stability of the Bcy1S145A variant. However, in
cells containing BCY1S145A, the presence of Gpb1 and Gpb2
causes about a twofold decrease in FLO11 RNA expression.
Wild-type cells containing BCY1S145A display a level of
FLO11 RNA that is 75% of the level seen when these cells
contain BCY1. Thus, the BCY1S145A mutation causes a de-
crease in the level of signaling in both wild-type and gpb1
gpb2 cells, but it does not eliminate the effect of gpb1
gpb2 mutations on signaling. In wild-type cells containing
BCY1S145E, FLO11 RNA is present at a slightly higher level
than in the same cells containing BCY1. Deletion of GPB1
and GPB2 in cells containing BCY1S145E causes a sixfold
increase in FLO11 RNA levels. These results reveal an in-
verse correlation between Bcy1 stability and signaling
through the PKA pathway, as would be expected for a
negative regulator of PKA activity.
To provide more support for the idea that PKA activity is
controlled by the effects of Gpb1 and Gpb2 on Bcy1, the
degree of phosphorylation of a known PKA substrate was
measured. The transcriptional repressor Sﬂ1 negatively reg-
ulates expression of the FLO11 gene (Robertson and Fink,
1998; Conlan and Tzamarias, 2001; Pan and Heitman, 2002).
Phosphorylation of Sﬂ1 by PKA prevents its binding to the
FLO11 promoter, resulting in increased FLO11 expression
(Conlan and Tzamarias, 2001; Pan and Heitman, 2002). Sﬂ1
contains two sites with the PKA consensus phosphorylation
sequence, RRXS. To determine the effect of gpb1 gpb2
Figure 4. Bcy1S145A retains the effect of gpb1 gpb2 mutations on
Bcy1 phosphorylation and PKA activity. (A) Cell lysates were pre-
pared from the following strains grown in 0.05% glucose to log
phase: strain HS287-2C (bcy1) carrying plasmid 313pBHB1-416 (HA-
BCY1, WT), strain HS293-10D (gpb1 gpb2 bcy1) carrying plasmid
313pBHB1-416, strain HS287-2C carrying plasmid pBHBSA-313.4
(HA-BCY1, SA), strain HS293-10D carrying plasmid pBHBSA-313.4,
strain HS287-2C carrying plasmid pBCS145E-313.3 (HA-BCY1, SE),
and strain HS293-10D carrying plasmid pBCS145E-313.3. Lysates
were analyzed by SDS-PAGE and immunoblotting with anti-HA
and anti-actin antibodies. (B) RNA isolated from the strains de-
scribed in A was assayed for the relative amount of FLO11 and
ACT1 RNA by real-time RT-PCR. Values are plotted as the relative
amount of FLO11 RNA normalized to ACT1 RNA and are the mean
and SD from three independent experiments. Asterisk indicates
p0.0001. (C) Sﬂ1-myc was immunoprecipitated with anti-myc
9E10 mAb from the strains described in A carrying plasmid pXP181.
Immunoprecipitated protein was analyzed by SDS-PAGE and im-
munoblotting with anti-phospho-PKA substrate (RRXSp) and anti-
myc antibodies. Protein levels were quantiﬁed by infrared imaging,
and relative Sﬂ1 phosphorylation was calculated as the amount of
phosphorylated Sﬂ1 divided by the amount of total Sﬂ1, normalized
to the value obtained in strain HS287-2C carrying plasmid
313pBHB1-416.
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was probed with an antibody that recognizes phosphory-
lated PKA sites. In cells containing wild-type Bcy1,
Bcy1S145A, and Bcy1S145E, deletion of GPB1 and GPB2 causes
a ﬁve- to sevenfold increase in the level of Sﬂ1 phosphory-
lation at the PKA sites (Figure 4C). However, the level of Sﬂ1
phosphorylation in GPB1 GPB2 and gpb1 gpb2 cells con-
taining the Bcy1S145A variant is 40% lower than in the cor-
responding strains containing wild-type Bcy1. These re-
sults establish that the BCY1S145A mutation does not
eliminate the effect of gpb1 gpb2 mutations on in vivo
PKA activity. The BCY1S145A mutation does, however,
decrease the level of PKA activity in both in GPB1 GPB2
and gpb1 gpb2 cells, most likely due to increased sta-
bility of the Bcy1S145A variant.
Yak1 Kinase Is Not Required for Phosphorylation of Bcy1
in a Gpb-dependent Manner
In addition to PKA catalytic subunits, another kinase that
phosphorylates Bcy1 is Yak1 (Werner-Washburne et al.,
1991; Grifﬁoen et al., 2001). Yak1 is a growth inhibitor that
acts in opposition to PKA (Garrett and Broach, 1989). Cells
containing a yak1 mutation lack a phosphorylated form of
Bcy1 that increases in abundance when glucose is depleted
from the medium (Werner-Washburne et al., 1991; Grifﬁoen
et al., 2001). Therefore, Yak1 is a potential candidate for the
kinase that phosphorylates Bcy1 in a manner stimulated by
Gpb1 and Gpb2. However, an experiment designed to test
this possibility showed that deletion of YAK1 has no effect
on abundance or phosphorylation of Bcy1 in cells grown in
high or low concentrations of glucose (Figure 5A). These
results show that Yak1 is not the kinase responsible for
phosphorylation of Bcy1 at the site stimulated by Gpb1 and
Gpb2. This ﬁnding is consistent with the observation that
cells containing a yak1 mutation do not display phenotypes
associated with high PKA activity, such as increased FLO11
expression (Figure 1B).
Bcy1 Phosphorylation and Abundance Are Not Affected by
Activated Ras2
Cells containing gpb1 gpb2 mutations display a high level
of PKA activity that is associated with decreased Bcy1 abun-
dance and phosphorylation. It was therefore of interest to
determine whether these effects on Bcy1 are speciﬁc to gpb1
gpb2 mutations or are common to other mutations that
cause PKA activation. To address this question, the effect of
constitutively active Ras2 on Bcy1 was investigated in cells
grown in different concentrations of glucose. As described
above, deletion of GPB1 and GPB2 causes a decrease in Bcy1
abundance in cells grown in 2% glucose and eliminates the
appearance of a phosphorylated form of Bcy1 in cells grown
in 0.05% glucose (Figure 5B, lanes 1–4). In contrast, expres-
sion of constitutively active Ras2 has no effect on Bcy1
abundance or phosphorylation in cells grown in high or low
concentrations of glucose (Figure 5B, lanes 5–8). This con-
stitutively active allele of RAS2 has been shown to cause an
increase in PKA phosphorylation of the transcription factor
Msn2 that is similar to the increase caused by deletion of
GPB1 and GPB2 (Lu and Hirsch, 2005). Therefore, cells con-
taining constitutively active Ras2 and gpb1 gpb2 muta-
tions display comparable levels of increased PKA activity,
but the effect on Bcy1 abundance and phosphorylation is
speciﬁc to gpb1 gpb2 mutations. These results demon-
strate that the effects of gpb1 gpb2 mutations on Bcy1 are
not common to all mutations that cause PKA activation.
Gpb1 and Gpb2 Antagonize the Effects of PKA on Bcy1
Phosphorylation
The results presented above suggest that the Tpk proteins
and the kelch repeat proteins have antagonistic effects on the
function of Bcy1. Whereas PKA phosphorylation of Bcy1 is
associated with increased PKA activity, the effect of Gpb1
and Gpb2 on Bcy1 is associated with decreased PKA activ-
ity. To explore this idea further, the catalytic activity of PKA
was inhibited, and the effect of this inhibition on Bcy1 was
determined in GPB1 GPB2 and gpb1 gpb2 cells.
Inhibition of PKA activity was accomplished by using a
strain in which the TPK1, TPK2, and TPK3 genes have
been replaced by alleles encoding kinases with enzymatic
activity that is sensitive to the ATP analog 1NM-PP1
(Yorimitsu et al., 2007). Wild-type and Tpk analog–sensi-
tive (Tpkas) cells containing HA-BCY1 and HA-BCY1S145A
were grown to log phase in 2.0% glucose, and HA-Bcy1
was detected by immunoblot. Treatment of wild-type cells
with 1NM-PP1 has no effect on Bcy1, as expected (Figure
6A, lanes 1 and 2). However, treatment of Tpkas cells with
1NM-PP1 results in the appearance of phosphorylated
Bcy1 in cells grown in high glucose (Figure 6A, lanes 3
and 4). The same effect is observed in Tpkas cells contain-
ing the Bcy1S145A variant (Figure 6A, lanes 7 and 8). These
results indicate that, when glucose concentrations are
high, PKA activity prevents phosphorylation of Bcy1 on a
site other than S145.
To determine whether the function of Gpb1 and Gpb2 is
affected by inhibition of PKA activity, GPB1 GPB2 and gpb1
gpb2 cells that also contain Tpkas alleles were grown to log
phase in 0.05% glucose, and HA-Bcy1 was detected by im-
munoblot. In the absence of 1NM-PP1 treatment, there is less
phosphorylated Bcy1 in cells containing gpb1 gpb2 muta-
tions (Figure 6B, lanes 1 and 2), as described above. Treat-
Figure 5. Bcy1 phosphorylation and abundance are not affected by
a yak1 mutation or activated Ras2. (A) Cell lysates were prepared
from the following strains grown to log phase in the indicated
concentrations of glucose: strain HS287-2C (bcy1) carrying plasmid
313pBHB1-416 and strain HS309-8B (bcy1 yak1) carrying plasmid
313pBHB1-416. Lysates were analyzed by SDS-PAGE and immuno-
blotting with anti-HA and anti-actin antibodies. Protein levels were
quantiﬁed by infrared imaging, and numbers under the lanes are
the relative amount of HA-Bcy1 normalized to actin. (B) Cell lysates
were prepared from the following strains grown to log phase in the
indicated concentrations of glucose: strain HS287-2C (bcy1) carry-
ing plasmid 313pBHB1-416, strain HS293-10D (gpb1 gpb2 bcy1)
carrying plasmid 313pBHB1-416, strain HS287-2C carrying plasmid
313pBHB1-416 and vector YCplac111 (vec), and strain HS287-2C
carrying plasmids 313pBHB1-416 and pRAS2AV-111.9 (RAS2*). Ly-
sates were analyzed as described in A.
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phorylated Bcy1 that is essentially the same in GPB1 GPB2
and gpb1 gpb2 cells (Figure 6B, lanes 5 and 6). Similar
effects are seen with the Bcy1S145A variant (Figure 6B, lanes
3, 4, 7, and 8). Therefore, the effect of gpb1 gpb2 mutations
on Bcy1 phosphorylation is eliminated when PKA activity is
inhibited. These results suggest that Gpb1 and Gpb2 antag-
onize the effect of PKA activity on Bcy1 phosphorylation at
a site other than S145.
DISCUSSION
Deletion of GPB1 and GPB2 results in phenotypes that are
characteristic of increased activation of the cAMP-depen-
dent kinase PKA (Harashima and Heitman, 2002; Batlle et
al., 2003). Cells lacking Gpb1 and Gpb2 also display in-
creased phosphorylation of PKA substrates, such as the
stress-responsive transcription factor Msn2 (Lu and Hirsch,
2005). However, Gpb1 and Gpb2 do not appear to function
by regulating the synthesis or degradation of cAMP, because
deleting GPB1 and GPB2 has effects in cells that lack ade-
nylate cyclase and cAMP phosphodiesterases (Lu and Hir-
sch, 2005; Peeters et al., 2006). These results suggested that
Gpb1 and Gpb2 could directly control the activity of PKA.
Here we present evidence that is consistent with a model in
which Gpb1 and Gpb2 promote phosphorylation and stabi-
lization of Bcy1 in opposition to the effects of PKA catalytic
subunits.
The model shown in Figure 7 incorporates the following
ﬁndings. In gpb1 gpb2 mutants, Bcy1 abundance is low
because its rate of degradation is increased (Figure 3). When
the abundance of Bcy1 is low, the amount of free, active PKA
catalytic subunits is expected to be high. The effect of gpb1
gpb2 mutations on Bcy1 stability requires either serine or a
negatively charged amino acid at position 145 of Bcy1.
Serine-145 is the site at which Bcy1 is phosphorylated by
Tpk proteins (Kuret et al., 1988; Werner-Washburne et al.,
1991). Therefore, these observations suggest that phosphor-
ylation of Bcy1 by Tpk proteins targets it for degradation.
Phosphorylated Bcy1 could be recognized by F-box subunits
of the SCF E3 ubiquitin ligase, which target proteins that
contain a phosphorylated motif (Vodermaier, 2004).
In wild-type cells, Gpb1 and Gpb2 promote the phosphor-
ylation of Bcy1 at a site other than S145. The effect of Gpb1
and Gpb2 on Bcy1 phosphorylation increases as the concen-
tration of extracellular glucose decreases, indicating that
glucose blocks the function of Gpb1 and Gpb2. Loss of Gpb1
Figure 6. Inhibition of PKA results in phosphorylation of Bcy1. (A)
Cell lysates were prepared from the following strains grown in 2.0%
glucose that were untreated or treated with 5 M 1NM-PP1 for 90
min: strain W3031B carrying plasmid 313pBHB1-416 (TPK1/2/3, ;
HA-BCY1, WT), strain Y3527 (tpk1as tpk2 as tpk3 as) carrying plasmid
313pBHB1-416 (TPK1/2/3, as; HA-BCY1, WT), strain W3031B carrying
plasmid pBHBSA-313.4 (TPK1/2/3, ; HA-BCY1, SA), and strain
Y3527 carrying plasmid pBHBSA-313.4 (TPK1/2/3, as; HA-BCY1,
SA). Lysates were analyzed by SDS-PAGE and immunoblotting
with anti-HA antibody. (B) Cell lysates were prepared from the
following strains grown in 0.05% glucose that were untreated or
treated with 1 M 1NM-PP1 for 90 min: strain Y3527 (tpk1as tpk2as
tpk3as) carrying plasmid 313pBHB1-416 (HA-BCY1, WT), strain
Y3527.k1Tk2U (tpk1as tpk2 as tpk3 as gpb1 gpb2) carrying plasmid
313pBHB1-416, strain Y3527 carrying plasmid pBHBSA-313.4 (HA-
BCY1, SA), and strain Y3527.k1Tk2U carrying plasmid pBHBSA-
313.4. Lysates were analyzed by SDS-PAGE and immunoblotting
with anti-HA antibody.
Figure 7. Model for control of PKA activity
by Gpb1 and Gpb2. The PKA regulatory sub-
unit Bcy1 is phosphorylated on an unknown
site by a kinase that is inhibited by PKA
catalytic activity. This phosphorylation stabi-
lizes Bcy1 that has been phosphorylated at
serine-145 by PKA catalytic subunits and
causes Bcy1 to be a more efﬁcient inhibitor of
Tpk1, Tpk2, and Tpk3. In low glucose, Gpb1
and Gpb2 block the inhibitory effect of PKA
on the kinase that phosphorylates Bcy1. Un-
der these conditions, more Bcy1 is bound to
PKA catalytic subunits and the signal output
is low. In the absence of Gpb1 and Gpb2, PKA
inhibits the kinase that phosphorylates Bcy1,
and Bcy1 that is phosphorylated at serine-145
becomes unstable. Under these conditions,
less Bcy1 is bound to PKA catalytic subunits
and the signal output is high.
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not affect the stability of Bcy1S145A (Figure 3), suggesting
that Gpb-dependent phosphorylation stabilizes Bcy1 that is
phosphorylated at serine-145. However, Bcy1 that is not
phosphorylated at S145 can be phosphorylated at the Gpb-
dependent site, and this modiﬁcation has functional conse-
quences, as shown by the observation that Bcy1S145A is
subject to regulation by Gpb1 and Gpb2 (Figure 4). There-
fore, the decrease in PKA activity that is mediated by Gpb1
and Gpb2 probably results from both increased abundance
of Bcy1 combined with modiﬁcations that promote its bind-
ing to Tpk subunits. This model is supported by previous
results showing that there is less Bcy1 bound to the PKA
catalytic subunit Tpk1 in gpb1 gpb2 cells (Peeters et al.,
2006).
PKA catalytic subunits play a dual role in this regulatory
network. First, Tpk proteins phosphorylate Bcy1 at S145,
which causes it to be destabilized. Second, Tpk proteins
inhibit phosphorylation of Bcy1 by another kinase (Figure
6). The role of Gpb1 and Gpb2 is to prevent inhibition of this
kinase by Tpk proteins. This idea is based on the observation
that gpb1 gpb2 mutations do not affect Bcy1 phosphory-
lation in the absence of PKA activity. Therefore, the only role
of Gpb1 and Gpb2 is to antagonize the effect of PKA on the
Bcy1 kinase. Given that Tpk proteins have been shown to
interact with Gpb1 and Gpb2 (Peeters et al., 2006; Lu and
Hirsch, unpublished results), one possible mechanism to
explain these results is that binding of Gpb1 and Gpb2 to
Tpk proteins speciﬁcally blocks their interaction with the
kinase that phosphorylates Bcy1.
A different way in which Gpb1 and Gpb2 have been
proposed to function is by stabilizing Ira1 and Ira2, the
GAPs of yeast Ras (Harashima et al., 2006). These authors
presented a model in which the only two cellular targets of
Gpb1 and Gpb2 are the G subunit Gpa2 and Ras. In this
model, Gpb1 and Gpb2 regulate Gpa2 by inhibiting recep-
tor-G protein coupling, and they regulate Ras by stabiliza-
tion of RasGAPs. The results presented here do not support
the idea that Gpb1 and Gpb2 function solely as upstream
inhibitors of Gpa2 and Ras, because deletion of GPB1 and
GPB2 in a gpa2 ras2 strain has effects on FLO11 RNA
expression and Bcy1 phosphorylation. Instead, our results
support the conclusion that Bcy1 is a major target of Gpb1
and Gpb2, consistent with previous results showing that
Gpb1 and Gpb2 act downstream of adenylate cyclase (Lu
and Hirsch, 2005; Peeters et al., 2006). These ﬁndings do not
rule out the possibility that Ira1 and Ira2 are also regulated
by Gpb1 and Gpb2. However, a recent report showed that
Gpb1 promotes degradation of Ira2 (Phan et al., 2010), which
is the opposite effect of the one observed by Harashima et al.
(2006). Therefore, additional studies will be necessary to
resolve the question of how Gpb1 and Gpb2 regulate Ras-
GAP proteins.
Several lines of evidence indicate that adenylate cyclase
functions as a downstream effector of Gpa2 (Peeters et al.,
2007). However, this does not preclude the possibility that
Gpb1 and Gpb2 also function as Gpa2 effectors, as has been
proposed previously (Peeters et al., 2007). In this model,
binding of glucose to the cell surface receptor Gpr1 and
concomitant activation of Gpa2 would result in blocking the
inhibitory effect of Gpb1 and Gpb2 on downstream signaling
components. Support for this idea includes the observation
that deletion of GPB1 and GPB2 largely eliminates the neg-
ative effects of a gpa2 mutation, indicating that Gpb1 and
Gpb2 could function downstream of Gpa2 (Harashima and
Heitman, 2002; Batlle et al., 2003). Gpa2 and PKA catalytic
subunits bind to different domains of Gpb1 and Gpb2, sug-
gesting that the kelch repeat proteins could function as
scaffolding proteins that bring signaling components into
proximity with each other (Peeters et al., 2006). However,
binding of Gpb2 to Gpa2 is not dramatically increased when
Gpa2 is in the GTP-bound form compared with the GDP-
bound form (Peeters et al., 2006). Moreover, Gpb2 does not
interact with the region of Gpa2 that would be expected to
contact an effector (Niranjan et al., 2007), which includes the
Switch II region (2-helix) and the 3-5 and 4-6 loops of
the -subunit (Tesmer et al., 1997). Therefore, it is not clear
whether the relationship between Gpa2 and the kelch repeat
proteins represents a classical G protein-effector interaction.
Although the results presented here do not address the
question of whether Gpb1 and Gpb2 directly couple Gpa2 to
PKA, this model presents an attractive possibility for the
way in which the function of Gpb1 and Gpb2 could be
controlled by extracellular glucose concentration.
Processes involving signaling components are often
highly conserved, and it is likely that regulation of PKA by
kelch repeat proteins in response to nutritional conditions
occurs in other organisms. Kelch repeat proteins with func-
tions that have not been characterized are present in all
eukaryotic organisms. Evidence to support a conserved role
for Gpb1 and Gpb2 comes from the ﬁnding that their pres-
ence causes increased binding of the mammalian PKA reg-
ulatory and catalytic subunits (Peeters et al., 2006). Further
experiments will be necessary to establish whether regula-
tion of PKA regulatory subunit phosphorylation and stabil-
ity by kelch repeat proteins in response to nutritional con-
ditions is a widely conserved mechanism.
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